PublizoomCall for tenders Supplies
Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
Notice published in Dutch. The AI analysis summarises it for you in your language.
Tenders due closed — 1 June 2026 at 10:00
- Public buyer
- Ziekenhuis aan de Stroom vzw (ZAS)
Antwerpen - Place of performance
- 2030 Antwerpen
not published: buyer's address - Estimated value
- €7,129,200 excl. VAT
- Planned end of contract
- 1 July 2027
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 15 May 2026
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
10 lots
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
- Aankoop van ijzercarboxymaltose, paclitaxel (nanopartikels gebonden aan albumine), nilotinib, axitinib, pazopanib, tocilizumab, pomalidomide, denosumab en esketamine
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €269,390
- Median
- €449,863
- A quarter above
- €962,736
- This contract (estimated)
- €7,129,200
Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- Duomed Belgium nv · 3 contracts won
- Fresenius Kabi NV/SA · 2 contracts won
- BRAUN B MEDICAL NV · 2 contracts won
- Philips Belgium Commercial n.v. · 2 contracts won
- Tobrix · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst: aankoop CPT intra-vitreale injectie vzw Jessa Ziekenhuis · 22 October 2026 |
DE CEUNYNCK MEDICAL | €604,000 |
| Raamovereenkomst voor het leveren van Tocilizumab IV AZ Oudenaarde · 16 October 2026 |
Fresenius Kabi | €1,200,000 |
| Leveren van orale antibiotica UZ Leuven · 16 October 2026 |
Pfizer Viatris Arega Pharma EUMEDICA |
€1,032,354 |
| Leveren van parenterale en inhalatie antibiotica UZ Leuven · 12 October 2026 |
sandoz Viatris Fresenius Kabi ACCORD HEALTHCARE |
€26,847,462 |
| Fer injectable CHIREC · 7 October 2026 |
Viatris | €432,640 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 332905-2026.